Mechanisms, biologic sequelae and clinical benefits of bortezomib-induced immunogenic cell death in multiple myeloma

Authors :: Dharminder Chauhan
Eugenio Morelli
Ruben D. Carrasco
Giada Bianchi
Prabhal Rao
Kenneth C. Anderson
Annamaria Gulla
Nikhil C. Munshi
Mariateresa Fulciniti
Yu-Tzu Tai
Teru Hideshima
Srikanth Talluri
Mehmet Kemal Samur
Source :: Clinical Lymphoma Myeloma and Leukemia. 19:e162
Publication Year :: 2019
Publisher :: Elsevier BV, 2019.

Subjects :: Cancer Research
Oncology
Bortezomib
business.industry
Cancer research
medicine
Immunogenic cell death
Hematology
medicine.disease
business
Multiple myeloma
medicine.drug

Full Text Access

Tools